Código QR (código de barras bidimensional)

Real-World Outcomes Among Patients in the United States Receiving Tafamidis for Transthyretin Amyloid Cardiomyopathy

Abstract Introduction Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, often fatal disease. Tafamidis demonstrated efficacy in ATTR-CM clinical trials; however, real-world disease outcomes are not thoroughly characterized. We examined real-world outcomes among patients with wild-type...

Fuld beskrivelse

Na minha lista:
Principais autores: Daniel P. Judge, Margarita Udall, Andrew M. Rosen, Neil Lamarre, Elizabeth Nagelhout, Hanh Dung Dao, Mathew S. Maurer
Format: Artigo
Sprog:Inglês
Udgivet: Adis, Springer Healthcare 2025-12-01
Serier:Cardiology and Therapy
Fag:
ATTR-CM
Cardiovascular hospitalization
Heart failure
NT-proBNP
Real-world evidence
Tafamidis
Online adgang:https://doi.org/10.1007/s40119-025-00443-3
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker